Pfizer-BioNTech Shot for Children Under 5 Safe and Effective, FDA Staff Says

Share This Story, Choose Your Platform!

Food and Drug Administration staff said Sunday the coronavirus vaccine made by Pfizer and its German partner, BioNTech, for children younger than 5 is effective in producing a virus-blocking response and did not raise safety concerns, a prelude to a crucial review this week by the agency’s independent advisers. Read more…